BioStable Science & Engineering

Founded with a mission to innovate cardiovascular disease treatment, BioStable Science & Engineering focuses on developing advanced medical devices. The company’s core vision is to simplify and standardize aortic valve repair, thereby improving patient outcomes. BioStable's flagship product, the HAART™ Aortic Annuloplasty Device, is designed to resize, reshape, and stabilize the aortic valve, addressing issues such as dilatation and restoring normal valve function. Their market focus is on providing comprehensive solutions for aortic valve repair, particularly for conditions like isolated aortic insufficiency.

Notable individuals affiliated with BioStable include Scott Emami. The company has garnered attention from key investors in the medical device sector, contributing to its growth and development. BioStable’s HAART™ device has achieved significant milestones in clinical adoption, demonstrating its efficacy and reliability in aortic valve repair procedures. Overall, BioStable Science & Engineering has made a substantial impact by advancing cardiovascular treatment options and improving the quality of life for patients with aortic valve conditions.